Skip To Main Content
Lakshmikanth Tadepally on Muck Rack

Lakshmikanth Tadepally

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lakshmikanth

Contact Lakshmikanth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trial

|
By Matteo Simonelli, Agnese Losurdo, Pavlina Spiliopoulou, Vincenzo D’alonzo, Giovanni Amato, Mónica Valente, Hugo Barcenilla, Anette Johnsson, Laura Gonzalez, Laura González, Ziyang Tan, Petter Brodin, Michael Lahn, Giusy Di Conza, Rebeca Fernández Zorrilla, Lars van der Veen, Alessio Bevilacqua, Paramjit Kaur, Andrea Corsi, Nikhil Sindhwani, Mariaelena Occhipinti, Robert Snijder, Gregory Price, Emily Wood, Vincent Vuaroqueaux, Ming Poi, David Spetzler, Carmelo Carlo-Stella, Armando Santoro, Thomas Evans, Michele Maio, Lakshmikanth Tadepally, Tracey Hammett, Marco Durini, Ayad Abdul-Ahad, Aniko Meijer, Umberto Postiglione, Gillian Hopton, Anne-Lise Peille, Jill Graham
| Nature Verified
Open in Who Shared Issue with article?
See all 1 articles